{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:22:31Z","timestamp":1785460951206,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Canadian Institutes of Health Research"],"award-info":[{"award-number":["Canadian Institutes of Health Research"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44470-025-00025-z","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:54:31Z","timestamp":1767027271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nocturnal hypoxemia is associated with increased urine Kidney Injury Molecule-1 (KIM-1) in patients with obstructive sleep apnea"],"prefix":"10.1007","volume":"22","author":[{"given":"Andrew E.","family":"Beaudin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K.","family":"Raneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia B.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ Marcus Hirsch","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrhea","family":"Nocon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gakwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"S\u00e9ri\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. John","family":"Kimoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Skomro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib T.","family":"Ayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hanly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Canadian Sleep and Circadian Network (CSCN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"8","key":"25_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687.","journal-title":"Lancet Respir Med"},{"key":"25_CR2","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/jama.2020.3514","volume":"323","author":"DJ Gottlieb","year":"2020","unstructured":"Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323:1389\u2013400.","journal-title":"JAMA"},{"key":"25_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab267","volume":"45","author":"AE Beaudin","year":"2022","unstructured":"Beaudin AE, Raneri JK, Ahmed SB, et al. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45:zsab267.","journal-title":"Sleep"},{"key":"25_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.5664\/jcsm.4946","volume":"11","author":"B Abuyassin","year":"2015","unstructured":"Abuyassin B, Sharma K, Ayas NT, Laher I. Obstructive sleep apnea and kidney disease: a potential bidirectional relationship? J Clin Sleep Med. 2015;11:915\u201324.","journal-title":"J Clin Sleep Med"},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1378\/chest.14-0596","volume":"146","author":"PJ Hanly","year":"2014","unstructured":"Hanly PJ, Ahmed SB. Sleep apnea and the kidney: is sleep apnea a risk factor for chronic kidney disease? Chest. 2014;146:1114\u201322.","journal-title":"Chest"},{"key":"25_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1378\/chest.11-1809","volume":"141","author":"DDM Nicholl","year":"2012","unstructured":"Nicholl DDM, Ahmed SB, Loewen AHS, et al. Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest. 2012;141:1422\u201330.","journal-title":"Chest"},{"key":"25_CR7","doi-asserted-by":"publisher","first-page":"R931","DOI":"10.1152\/ajpregu.00552.2010","volume":"300","author":"RG Evans","year":"2011","unstructured":"Evans RG, Goddard D, Eppel GA, O\u2019Connor PM. Factors that render the kidney susceptible to tissue hypoxia in hypoxemia. Am J Physiol Regul Integr Comp Physiol. 2011;300:R931-40.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"25_CR8","doi-asserted-by":"publisher","first-page":"e0192084","DOI":"10.1371\/journal.pone.0192084","volume":"13","author":"B Abuyassin","year":"2018","unstructured":"Abuyassin B, Badran M, Ayas NT, Laher I. Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea. PLoS One. 2018;13:e0192084.","journal-title":"PLoS One"},{"key":"25_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/HYPERTENSIONAHA.110.152108","volume":"56","author":"GE Foster","year":"2010","unstructured":"Foster GE, Hanly PJ, Ahmed SB, Beaudin AE, Pialoux V, Poulin MJ. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin-system dependent mechanism. Hypertension. 2010;56:369\u201377.","journal-title":"Hypertension"},{"key":"25_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1164\/rccm.201502-0383OC","volume":"192","author":"AA Zalucky","year":"2015","unstructured":"Zalucky AA, Nicholl DDM, Hanly PJ, et al. Nocturnal hypoxemia severity and renin\u2013angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med. 2015;192:873\u201380.","journal-title":"Am J Respir Crit Care Med"},{"key":"25_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa228","volume":"44","author":"DM Nicholl","year":"2021","unstructured":"Nicholl DM, Hanly PJ, Zalucky AA, Handley GB, Sola DY, Ahmed SB. Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea. Sleep. 2021;44:zsaa228.","journal-title":"Sleep"},{"key":"25_CR12","doi-asserted-by":"crossref","unstructured":"Canales MT,Hagen EW, Barnet JH, Peppard PE, Derose SF. Sleep Apnea and Kidney Function Trajectory: Results From a 20-Year Longitudinal Study of Healthy Middle-Aged Adults. Sleep 2018;41:zsx181.","DOI":"10.1093\/sleep\/zsx181"},{"key":"25_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339\u201352.","journal-title":"Lancet"},{"key":"25_CR14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"25_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247\u201359.","journal-title":"Kidney Int"},{"key":"25_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0272-6386(03)00538-9","volume":"42","author":"A Kroeker","year":"2003","unstructured":"Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis. 2003;42:49\u201355.","journal-title":"Am J Kidney Dis"},{"key":"25_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473\u201385.","journal-title":"Nat Rev Nephrol"},{"key":"25_CR18","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2024;105:S117-314.","journal-title":"Kidney Int Suppl"},{"key":"25_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119156","volume":"24","author":"L Catanese","year":"2023","unstructured":"Catanese L, Siwy J, Mischak H, Wendt R, Beige J, Rupprecht H. Recent advances in urinary peptide and proteomic biomarkers in chronic kidney disease: a systematic review. Int J Mol Sci. 2023;24:9156.","journal-title":"Int J Mol Sci"},{"key":"25_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322:1294\u2013304.","journal-title":"JAMA"},{"key":"25_CR21","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.chest.2020.11.052","volume":"159","author":"AN Rimke","year":"2021","unstructured":"Rimke AN, Ahmed SB, Turin TC, et al. Effect of CPAP therapy on kidney function in patients with chronic kidney disease: a pilot randomized controlled trial. Chest. 2021;159:2008\u201319.","journal-title":"Chest"},{"key":"25_CR22","doi-asserted-by":"publisher","first-page":"zsae254","DOI":"10.1093\/sleep\/zsae254","volume":"48","author":"PJ Hanly","year":"2025","unstructured":"Hanly PJ, Ahmed SB. Obstructive sleep apnea and chronic kidney disease: time to move from association to causality and intervention. Sleep. 2025;48:zsae254.","journal-title":"Sleep"},{"key":"25_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.117798","volume":"555","author":"E Canki","year":"2024","unstructured":"Canki E, Kho E, Hoenderop JGJ. Urinary biomarkers in kidney disease. Clin Chim Acta. 2024;555:117798.","journal-title":"Clin Chim Acta"},{"key":"25_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/sj.ki.5002715","volume":"73","author":"WK Han","year":"2008","unstructured":"Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73:863\u20139.","journal-title":"Kidney Int"},{"key":"25_CR25","doi-asserted-by":"publisher","first-page":"F313","DOI":"10.1152\/ajprenal.00180.2006","volume":"292","author":"MH de Borst","year":"2007","unstructured":"de Borst MH, van Timmeren MM, Vaidya VS, et al. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by Blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Ren Physiol. 2007;292:F313\u201320.","journal-title":"Am J Physiol Ren Physiol"},{"key":"25_CR26","doi-asserted-by":"publisher","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","volume":"286","author":"T Ichimura","year":"2004","unstructured":"Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004;286:F552-63.","journal-title":"Am J Physiol Renal Physiol"},{"key":"25_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.2175","volume":"212","author":"MM van Timmeren","year":"2007","unstructured":"van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212:209\u201317.","journal-title":"J Pathol"},{"key":"25_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","volume":"78","author":"JH Ix","year":"2021","unstructured":"Ix JH, Shlipak MG. The promise of tubule biomarkers in kidney disease: a review. Am J Kidney Dis. 2021;78:719\u201327.","journal-title":"Am J Kidney Dis"},{"key":"25_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.17219\/acem\/123356","volume":"29","author":"M Nowicki","year":"2020","unstructured":"Nowicki M, Zawiasa-Bryszewska A, Taczykowska M, Bialasiewicz P, Nowak D. The pattern of overnight changes in novel markers of acute kidney injury in patients with obstructive sleep apnea. Adv Clin Exp Med. 2020;29:1065\u201372.","journal-title":"Adv Clin Exp Med"},{"key":"25_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1164\/rccm.201403-0526OC","volume":"190","author":"DDM Nicholl","year":"2014","unstructured":"Nicholl DDM, Hanly PJ, Poulin MJ, et al. Evaluation of continuous positive airway pressure therapy on renin\u2013angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med. 2014;190:572\u201380.","journal-title":"Am J Respir Crit Care Med"},{"key":"25_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1053\/j.ajkd.2012.05.014","volume":"60","author":"CA Peralta","year":"2012","unstructured":"Peralta CA, Katz R, Bonventre JV, et al. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2012;60:904\u201311.","journal-title":"Am J Kidney Dis"},{"key":"25_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/01.tp.0000295982.78039.ef","volume":"84","author":"MM van Timmeren","year":"2007","unstructured":"van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. 2007;84:1625\u201330.","journal-title":"Transplantation"},{"key":"25_CR33","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1093\/sleep\/16.suppl_8.S132","volume":"16","author":"FG Issa","year":"1993","unstructured":"Issa FG, Morrison D, Hadjuk E, et al. Digital monitoring of obstructive sleep apnea using snoring sound and arterial oxygen saturation. Sleep. 1993;16:S132.","journal-title":"Sleep"},{"key":"25_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5664\/jcsm.26861","volume":"3","author":"MK Erman","year":"2007","unstructured":"Erman MK, Stewart D, Einhorn D, Gordon N, Casal E. Validation of the ApneaLink\u2122 for the screening of sleep apnea: a novel and simple single-channel recording device. J Clin Sleep Med. 2007;3:387\u201392.","journal-title":"J Clin Sleep Med"},{"key":"25_CR35","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1378\/chest.128.4.2166","volume":"128","author":"PR Westbrook","year":"2005","unstructured":"Westbrook PR, Levendowski DJ, Cvetinovic M, et al. Description and validation of the Apnea Risk Evaluation System: a novel method to diagnose sleep apnea-hypopnea in the home. Chest. 2005;128:2166\u201375.","journal-title":"Chest"},{"key":"25_CR36","volume-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rule, Terminology and Technical Specifications, Version 2.2","author":"RB Berry","year":"2015","unstructured":"Berry RB, Brooks R, Gamaldo CE. The AASM manual for the scoring of sleep and associated events: rule, terminology and technical specifications, version 2.2. Darien, Illinois: American Academy of Sleep Medicine; 2015."},{"key":"25_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540\u20135.","journal-title":"Sleep"},{"key":"25_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"25_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"25_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1053\/j.ajkd.2012.11.033","volume":"61","author":"JR Dominguez","year":"2013","unstructured":"Dominguez JR, Kestenbaum B, Chonchol M, et al. Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) study. Am J Kidney Dis. 2013;61:555\u201363.","journal-title":"Am J Kidney Dis"},{"key":"25_CR41","first-page":"15","volume":"11","author":"T Gunasekara","year":"2023","unstructured":"Gunasekara T, Herath C, De Silva P, Jayasundara N. Exploring the Utility of Urinary Creatinine Adjustment for KIM-1, NGAL, and Cystatin C for the Assessment of Kidney Function: Insights from the C-KidnEES Cohort. Children (Basel). 2023;11:15.","journal-title":"Children (Basel)"},{"key":"25_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1513\/AnnalsATS.202004-313OC","volume":"18","author":"AE Beaudin","year":"2021","unstructured":"Beaudin AE, Raneri JK, Ayas NT, et al. Cognitive function in a sleep clinic cohort of patients with obstructive sleep apnea. Ann Am Thorac Soc. 2021;18:865\u201375.","journal-title":"Ann Am Thorac Soc"},{"key":"25_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.smrv.2009.08.001","volume":"14","author":"MA Grandner","year":"2010","unstructured":"Grandner MA, Patel NP, Gehrman PR, Perlis ML. Pack AI problems associated with short sleep: bridging the gap between laboratory and epidemiological studies. Sleep Med Rev. 2010;14:239\u201347.","journal-title":"Sleep Med Rev"},{"key":"25_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","volume":"2","author":"CH Bastien","year":"2001","unstructured":"Bastien CH, Valli\u00e8res A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med Clin. 2001;2:297\u2013307.","journal-title":"Sleep Med Clin"},{"key":"25_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac088","volume":"45","author":"AE Beaudin","year":"2022","unstructured":"Beaudin AE, Raneri JK, Ahmed S, et al. Association of insomnia and short sleep duration, alone or with comorbid obstructive sleep apnea, and the risk of chronic kidney disease. Sleep. 2022;45:zsac088.","journal-title":"Sleep"},{"key":"25_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.02.015","volume":"120","author":"K Gooch","year":"2007","unstructured":"Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120:e2801\u20137.","journal-title":"Am J Med"},{"key":"25_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/j.ajkd.2019.07.012","volume":"75","author":"Z Al-Aly","year":"2020","unstructured":"Al-Aly Z, Maddukuri G, Xie Y. Proton pump inhibitors and the kidney: implications of current evidence for clinical practice and when and how to deprescribe. Am J Kidney Dis. 2020;75:497\u2013507.","journal-title":"Am J Kidney Dis"},{"key":"25_CR48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","volume":"20","author":"EF Schisterman","year":"2009","unstructured":"Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20:488\u201395.","journal-title":"Epidemiology"},{"key":"25_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237\u201344.","journal-title":"Kidney Int"},{"key":"25_CR50","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/oby.21070","volume":"23","author":"N Xiao","year":"2015","unstructured":"Xiao N, Devarajan P, Inge TH, Jenkins TM, Bennett M, Mitsnefes MM. Subclinical kidney injury before and 1 year after bariatric surgery among adolescents with severe obesity. Obesity. 2015;23:1234\u20138.","journal-title":"Obesity"},{"key":"25_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-014-2976-3","volume":"30","author":"W Ding","year":"2015","unstructured":"Ding W, Mak RH. Early markers of obesity-related renal injury in childhood. Pediatr Nephrol. 2015;30:1\u20134.","journal-title":"Pediatr Nephrol"},{"key":"25_CR52","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","volume":"324","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Wang Y, Zhao X, et al. Obesity and chronic kidney disease. Am J Physiol Endocrinol Metab. 2023;324:E24\u201341.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"25_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117698669","volume":"4","author":"CP Kovesdy","year":"2017","unstructured":"Kovesdy CP, Furth SL, Zoccali C. World kidney day steering C obesity and kidney disease: hidden consequences of the epidemic. Can J Kidney Health Dis. 2017;4:2054358117698669.","journal-title":"Can J Kidney Health Dis"},{"key":"25_CR54","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1113\/EP086051","volume":"102","author":"AE Beaudin","year":"2017","unstructured":"Beaudin AE, Waltz X, Hanly PJ, Poulin MJ. Impact of obstructive sleep Apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation. Exp Physiol. 2017;102:743\u201363.","journal-title":"Exp Physiol"},{"key":"25_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11906-010-0135-1","volume":"12","author":"GA Adeseun","year":"2010","unstructured":"Adeseun GA, Rosas SE. The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep. 2010;12:378\u201383.","journal-title":"Curr Hypertens Rep"},{"key":"25_CR56","doi-asserted-by":"publisher","first-page":"e167731","DOI":"10.1172\/jci.insight.167731","volume":"8","author":"Y Wen","year":"2023","unstructured":"Wen Y, Xu L, Melchinger I, et al. Longitudinal biomarkers and kidney disease progression after acute kidney injury. JCI Insight. 2023;8:e167731.","journal-title":"JCI Insight"},{"key":"25_CR57","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2217\/bmm.14.36","volume":"8","author":"SJ McWilliam","year":"2014","unstructured":"McWilliam SJ, Antoine DJ, Sabbisetti V, et al. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark Med. 2014;8:1189\u201397.","journal-title":"Biomark Med"}],"updated-by":[{"DOI":"10.1007\/s44470-025-00026-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000}}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-025-00025-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44470-025-00025-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-025-00025-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:02:21Z","timestamp":1769666541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44470-025-00025-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s44470-025-00025-z","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s44470-025-00026-y","URL":"https:\/\/doi.org\/10.1007\/s44470-025-00026-y","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance to the Declaration of Helsinki and approved by the University of British Columbia (UBC) Clinical Research Ethics Board (H16-00422), University of Calgary (UC) Conjoint Health Research Ethics Board (REB16-0211), University of Saskatchewan (US) Biomedical Research Ethics Board (BIO-REB16-106), McGill University Health Centre Research Ethics Board (MEO-10-2019-4718), and Institut Universitaire de Cardiologie et de Pneumologie de Quebec at Universit\u00e9 Laval Research Ethics Board (MP-10-2018-2938). Participants were informed of study requirements prior to providing written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Financial\n                      : A.E.B. reports receiving conference travel funding from Cerebra Medical Ltd to present research findings outside the submitted work; R.P.S reports having received consulting fees from Resmed, GSK and AstraZeneca outside the submitted work; N.A. reports consulting or speaking fees from Jazz Pharmaceuticals, Cerebra Medical Ltd, Powell Mansfield Inc., Eli Lilly, and Nox Medical in the last 3 years (all <$5000), and grant support from Apnimed; P.J.H reports having received financial support and equipment (CPAP units) from Philips Respironics for clinical research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}